Vitiligo outpatient management in the United States: findings from the 2012-2019 National Ambulatory Medical care Survey (NAMCS)

J Dermatolog Treat. 2024 Dec;35(1):2311793. doi: 10.1080/09546634.2024.2311793. Epub 2024 Feb 11.

Gaurav N Pathak^{1

2}, Anurag N Pathak³, Vibha Mital¹, Jimmy Dhillon¹, Steven R Feldman^{2

4

5

6}, Babar K Rao^{1

7}

¹ Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey.
² Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
³ Department of Computer Science, Rutgers University School of Arts and Sciences, New Brunswick, New Jersey.
⁴ Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
⁵ Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
⁶ Department of Dermatology, University of Southern Denmark, Odense, Denmark.
⁷ Department of Dermatology, Rao Dermatology, Atlantic Highlands, New Jersey.

No abstract available

Keywords: NAMCS; Vitiligo; ambulatory care; calcineurin inhibitor; corticosteroid; national ambulatory medical care survey.

MeSH terms